These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 18038290

  • 1. The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
    Hokland SL, Horsman MR.
    Int J Hyperthermia; 2007 Nov; 23(7):599-606. PubMed ID: 18038290
    [Abstract] [Full Text] [Related]

  • 2. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R, Horsman MR.
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F, Stuart OA, Glehen O, Urano M, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preclinical studies to predict efficacy of vascular changes induced by combretastatin a-4 disodium phosphate in patients.
    Nielsen T, Murata R, Maxwell RJ, Stødkilde-Jørgensen H, Ostergaard L, Horsman MR.
    Int J Radiat Oncol Biol Phys; 2008 Mar 01; 70(3):859-66. PubMed ID: 18164835
    [Abstract] [Full Text] [Related]

  • 13. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y, Murayama C, Maezawa H, Mori T.
    Tokai J Exp Clin Med; 1984 Oct 01; 9(4):331-7. PubMed ID: 6537042
    [Abstract] [Full Text] [Related]

  • 14. Combination of vascular targeting agents with thermal or radiation therapy.
    Horsman MR, Murata R.
    Int J Radiat Oncol Biol Phys; 2002 Dec 01; 54(5):1518-23. PubMed ID: 12459380
    [Abstract] [Full Text] [Related]

  • 15. Segmentation of dynamic contrast enhanced magnetic resonance imaging data.
    Nielsen T, Mouridsen K, Maxwell RJ, Stødkilde-Jørgensen H, Østergaard L, Horsman MR.
    Acta Oncol; 2008 Dec 01; 47(7):1265-70. PubMed ID: 18661437
    [Abstract] [Full Text] [Related]

  • 16. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
    Overgaard J, Radacic MM, Grau C.
    Cancer Res; 1991 Jan 15; 51(2):707-11. PubMed ID: 1985787
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.